The North America digital therapeutics market size surpassed USD 3.64 billion in 2025 and is predicted to reach around USD 38.2 billion by 2035, registering a CAGR of 26.5% from 2026 to 2035. Due to increasing adoption of software- based interventions management and mental health care. health care systems are integrating these solutions to improve patient outcomes and reduce costs.
North America Digital Therapeutics Market Statical Scope
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 3.64 Billion |
| Market Size in 2026 | USD 4.6 Billion |
| Market Size by 2035 | USD 38.2 Billion |
| CAGR 2026 to 2035 | 26.5% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
Growth factors include rising prevalence of lifestyle- related disorders, a strong digital health infrastructure, and growing acceptance of remote patient monitoring. insurance support approvals are also boost in market adoption across hospitals and clinics.
Technologies such as artificial intelligence , mobile health apps, in cloud- based data forms are transforming treatment delivery. these innovations enable personalised, data-driven therapies, improving patient engagement, adherence, and overall healthcare efficiency in the region.
North America Digital Therapeutics Market, By Application, 2025
| Segments | Shares (%) |
| Diabetes | 32.00% |
| Obesity | 18.00% |
| Cardiovascular Diseases (CVD) | 16.00% |
| Respiratory Diseases | 11.00% |
| CNS Diseases | 10.00% |
| Smoking Cessation | 8.00% |
| Others | 5.00% |
- Diabetes - The segment dominated the market with a 32.00% share, due to high disease burden, need for continuous glucose monitoring, and growing adoption of personalised digital care solution.
- Obesity - The segment accounted for 18.00% of the total market share, due to rising sedentary lifestyles, unhealthy diets, and growing use of app-based weight management and behavioural modification programs.
- Cardiovascular Diseases (CVD) - The segment accounted for 16.00% of the total market share, due to increasing heart- related disorders, demand for remote monitoring, and digital tools supporting lifestyle and medication adherence management.
North America Digital Therapeutics Market, By End-Use, 2025
| Segments | Shares (%) |
| Patients | 34.00% |
| Providers | 26.00% |
| Payers | 18.00% |
| Employers | 14.00% |
| Others | 8.00% |
- Patients - The segment dominated the market with a 34.00% share, due to growing self-care awareness, easy access to mobile health apps, and preference for personalised at- home treatment solutions.
- Providers - The segment accounted for 26.00% of the total market share, due to rising hospital adoption, clinical integration of digital tools, an improved patient management through data-driven treatment decisions.
- Payers - The segment accounted for 18.00% of the total market share, due to insurance coverage, focus on cost- effective care, and reduction of digital tools to reduce long-term healthcare expenses and claims.
Segments Covered in the Report
By Application
- Diabetes
- Obesity
- Cardiovascular Diseases (CVD)
- Respiratory Diseases
- Smoking Cessation
- CNS Diseases
- Others
By End-Use
- Patients
- Providers
- Payers
- Employers
- Others
List of Tables & Figures
List of Tables
• Table 1: North America Digital Therapeutics Market Size, by Application, 2025-2035 (USD Billion)
• Table 2: North America Digital Therapeutics Market Size, by End-Use, 2025-2035 (USD Billion)
• Table 3: North America Digital Therapeutics Market Size, by Diabetes, 2025-2035 (USD Billion)
• Table 4: North America Digital Therapeutics Market Size, by Obesity, 2025-2035 (USD Billion)
• Table 5: North America Digital Therapeutics Market Size, by Cardiovascular Diseases (CVD), 2025-2035 (USD Billion)
• Table 6: North America Digital Therapeutics Market Size, by Respiratory Diseases, 2025-2035 (USD Billion)
• Table 7: North America Digital Therapeutics Market Size, by Smoking Cessation, 2025-2035 (USD Billion)
• Table 8: North America Digital Therapeutics Market Size, by CNS Diseases, 2025-2035 (USD Billion)
• Table 9: North America Digital Therapeutics Market Size, by Others, 2025-2035 (USD Billion)
• Table 10: North America Digital Therapeutics Market Size, by Patients, 2025-2035 (USD Billion)
• Table 11: North America Digital Therapeutics Market Size, by Providers, 2025-2035 (USD Billion)
• Table 12: North America Digital Therapeutics Market Size, by Payers, 2025-2035 (USD Billion)
• Table 13: North America Digital Therapeutics Market Size, by Employers, 2025-2035 (USD Billion)
• Table 14: North America Digital Therapeutics Market Size, by Others, 2025-2035 (USD Billion)
List of Figures
• Figure 1: North America Digital Therapeutics Market Share, by Application, 2025 (%)
• Figure 2: North America Digital Therapeutics Market Share, by End-Use, 2025 (%)
• Figure 3: North America Digital Therapeutics Market Forecast, 2025-2035 (USD Billion)
• Figure 4: Diabetes Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 5: Obesity Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 6: Cardiovascular Diseases (CVD) Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 7: Respiratory Diseases Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 8: Smoking Cessation Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 9: CNS Diseases Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 10: Others Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 11: Patients Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 12: Providers Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 13: Payers Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 14: Employers Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 15: Others Segment Market Forecast, 2025-2035 (USD Billion)
Research Methodology
Related Databooks
March 2026
March 2026
March 2026
March 2026
sales@precedenceresearch.com
+1 804-441-9344
Download Databook
Schedule a Meeting